These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33582159)

  • 1. Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes.
    Madsen A; Krause J; Höppner G; Hirt MN; Tan WLW; Lim I; Hansen A; Nikolaev VO; Foo RSY; Eschenhagen T; Stenzig J
    J Mol Cell Cardiol; 2021 May; 154():115-123. PubMed ID: 33582159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility.
    Madsen A; Höppner G; Krause J; Hirt MN; Laufer SD; Schweizer M; Tan WLW; Mosqueira D; Anene-Nzelu CG; Lim I; Foo RSY; Hansen A; Eschenhagen T; Stenzig J
    Circulation; 2020 Oct; 142(16):1562-1578. PubMed ID: 32885664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors.
    Stenzig J; Hirt MN; Löser A; Bartholdt LM; Hensel JT; Werner TR; Riemenschneider M; Indenbirken D; Guenther T; Müller C; Hübner N; Stoll M; Eschenhagen T
    Basic Res Cardiol; 2016 Jan; 111(1):9. PubMed ID: 26680771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
    Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
    J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased length-dependent activation of human engineered heart tissue after chronic α
    Rupert C; López JE; Cortez-Toledo E; De la Cruz Cabrera O; Chesler NC; Simpson PC; Campbell SG; Baker AJ
    Am J Physiol Heart Circ Physiol; 2023 Mar; 324(3):H293-H304. PubMed ID: 36637971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes.
    Fang X; Poulsen RR; Wang-Hu J; Shi O; Calvo NS; Simmons CS; Rivkees SA; Wendler CC
    FASEB J; 2016 Sep; 30(9):3238-55. PubMed ID: 27306334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.
    Tiburcy M; Didié M; Boy O; Christalla P; Döker S; Naito H; Karikkineth BC; El-Armouche A; Grimm M; Nose M; Eschenhagen T; Zieseniss A; Katschinksi DM; Hamdani N; Linke WA; Yin X; Mayr M; Zimmermann WH
    Circ Res; 2011 Oct; 109(10):1105-14. PubMed ID: 21921264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.
    Hirt MN; Boeddinghaus J; Mitchell A; Schaaf S; Börnchen C; Müller C; Schulz H; Hubner N; Stenzig J; Stoehr A; Neuber C; Eder A; Luther PK; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2014 Sep; 74():151-61. PubMed ID: 24852842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats.
    Stenzig J; Schneeberger Y; Löser A; Peters BS; Schaefer A; Zhao RR; Ng SL; Höppner G; Geertz B; Hirt MN; Tan W; Wong E; Reichenspurner H; Foo RS; Eschenhagen T
    J Mol Cell Cardiol; 2018 Jul; 120():53-63. PubMed ID: 29792884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac-specific microRNA-125b deficiency induces perinatal death and cardiac hypertrophy.
    Chen CY; Lee DS; Choong OK; Chang SK; Hsu T; Nicholson MW; Liu LW; Lin PJ; Ruan SC; Lin SW; Hu CY; Hsieh PCH
    Sci Rep; 2021 Jan; 11(1):2377. PubMed ID: 33504864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae.
    Mannhardt I; Eder A; Dumotier B; Prondzynski M; Krämer E; Traebert M; Söhren KD; Flenner F; Stathopoulou K; Lemoine MD; Carrier L; Christ T; Eschenhagen T; Hansen A
    Toxicol Sci; 2017 Jul; 158(1):164-175. PubMed ID: 28453742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Interventions to Prevent Hypertrophy-Induced Alterations in Contractile Properties In Vitro.
    Geraets IME; Coumans WA; Strzelecka A; Schönleitner P; Antoons G; Schianchi F; Willemars MMA; Kapsokalyvas D; Glatz JFC; Luiken JJFP; Nabben M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts.
    Han P; Li W; Yang J; Shang C; Lin CH; Cheng W; Hang CT; Cheng HL; Chen CH; Wong J; Xiong Y; Zhao M; Drakos SG; Ghetti A; Li DY; Bernstein D; Chen HS; Quertermous T; Chang CP
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1772-81. PubMed ID: 26952936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Engineered Heart Tissue: Analysis of Contractile Force.
    Mannhardt I; Breckwoldt K; Letuffe-Brenière D; Schaaf S; Schulz H; Neuber C; Benzin A; Werner T; Eder A; Schulze T; Klampe B; Christ T; Hirt MN; Huebner N; Moretti A; Eschenhagen T; Hansen A
    Stem Cell Reports; 2016 Jul; 7(1):29-42. PubMed ID: 27211213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria and Cardiac Hypertrophy.
    Facundo HDTF; Brainard RE; Caldas FRL; Lucas AMB
    Adv Exp Med Biol; 2017; 982():203-226. PubMed ID: 28551789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes.
    Ulmer BM; Stoehr A; Schulze ML; Patel S; Gucek M; Mannhardt I; Funcke S; Murphy E; Eschenhagen T; Hansen A
    Stem Cell Reports; 2018 Mar; 10(3):834-847. PubMed ID: 29503093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired mitophagy facilitates mitochondrial damage in Danon disease.
    Hashem SI; Murphy AN; Divakaruni AS; Klos ML; Nelson BC; Gault EC; Rowland TJ; Perry CN; Gu Y; Dalton ND; Bradford WH; Devaney EJ; Peterson KL; Jones KL; Taylor MRG; Chen J; Chi NC; Adler ED
    J Mol Cell Cardiol; 2017 Jul; 108():86-94. PubMed ID: 28526246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophy induced KIF5B controls mitochondrial localization and function in neonatal rat cardiomyocytes.
    Tigchelaar W; de Jong AM; Bloks VW; van Gilst WH; de Boer RA; Silljé HH
    J Mol Cell Cardiol; 2016 Aug; 97():70-81. PubMed ID: 27094714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism.
    Ulmer BM; Eschenhagen T
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118471. PubMed ID: 30954570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.